Cempra to Present at the Jefferies 2017 Global Healthcare Conference
02. Juni 2017 07:00 ET
|
Cempra, Inc.
CHAPEL HILL, N.C., June 02, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and...
Cempra Presents Data on Ophthalmic Solithromycin at ARVO
10. Mai 2017 07:00 ET
|
Cempra, Inc.
CHAPEL HILL, N.C., May 10, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Reports First Quarter 2017 Financial Results and Provides Corporate Update
28. April 2017 07:00 ET
|
Cempra, Inc.
CHAPEL HILL, N.C., April 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Presents Data at ECCMID Highlighting Need for New CABP Therapies and Activity of Solithromycin in Key Population Groups
21. April 2017 07:00 ET
|
Cempra, Inc.
CHAPEL HILL, N.C., April 21, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Report First Quarter 2017 Financial Results
13. April 2017 07:00 ET
|
Cempra, Inc.
CHAPEL HILL, N.C., April 13, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and...
Cempra to Present at the 16th Annual Needham & Company Healthcare Conference
29. März 2017 07:00 ET
|
Cempra, Inc.
CHAPEL HILL, N.C., March 29, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and...
Cempra Withdraws Solithromycin Marketing Authorization Application in Europe
28. März 2017 07:00 ET
|
Cempra, Inc.
CHAPEL HILL, N.C., March 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and...
Cempra Retains Morgan Stanley to Lead Review of Strategic Business Options
13. März 2017 07:00 ET
|
Cempra, Inc.
CHAPEL HILL, N.C., March 13, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and...
Cempra to Present at 29th Annual ROTH Conference
03. März 2017 07:00 ET
|
Cempra, Inc.
CHAPEL HILL, N.C., March 03, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and...
Cempra Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results
28. Februar 2017 06:45 ET
|
Cempra, Inc.
—Management to host webcast and conference call today at 8:45 a.m. ET— CHAPEL HILL, N.C., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company...